FdaApplication
NDA 211994
Identifiers
- fda_app_no: NDA211994
Properties
| Property | Value |
|---|---|
| applicant_name | VIIV HEALTHCARE CO |
| application_type | NDA |
| approval_date | 2019-04-08 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DOVATO | DOLUTEGRAVIR SODIUM; LAMIVUDINE | EQ 50MG BASE;300MG | TABLET;ORAL |
1 product